|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | West Nile Virus IgM ELISA | Bevacizumab (Avastin®) ELISA | Complement System Screen ELISA Assay | T4 (Free) ELISA Assay | Triiodothyronine (Free) ELISA Assay |
| Catalog Number | IB05105 | TM09010 | COMPL 300 RUO | IB19106 | IB79136 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of human IgM antibodies directed against the West Nile virus in serum or plasma (EDTA, citrate, heparin). For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The Wieslab® Complement system Screen kit is an enzyme immunoassay for the determination of functional classical, MBL and alternative complement pathways in human serum. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of free Thyroxine (fT4) in human serum. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the quantitative determination of Free Triiodothyronine (fT3) concentration in human serum. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | West Nile Virus IgM | Bevacizumab (Avastin®) | Human NfL (Neurofilament light chain) | T4 (Free) | Amyloid Beta (1-42) |
| Sample Type | Serum or plasma (EDTA, citrate, heparin). | Serum and plasma. | Cerebrospinal fluids | Serum | Blood Plasma, CSF, Serum, Cell Culture Media, Extract from Brain Tissue |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A calculated cut-off value is used to interpret results of unknowns. | 0 / 6 to 200 ng/mL | Inquire | 0.45 to 7.70 ng/dL | 0.9 to 19.0 pg/mL |
| Sensitivity | > 99% | 2 ng/mL | 10.2 pg/mL | Inquire | 4.03 pg/mL |
| Assay Time | 1 hour (37°C) + 30 min. (37°C) + 30 min. (37°C) = 2 hours total incubation time. | 1 hour, 45 min. total incubation time. | 2 hrs (incubation) | 1 hr 15 mins (incubation) | 1 hr 20 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |